Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.
about
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control studyAssociation between vancomycin-resistant Enterococci bacteremia and ceftriaxone usagePatient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic reviewMultidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains.Risk factors for methicillin-resistant Staphylococcus aureus bacteraemia differ depending on the control group chosen.Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.Response to emerging infection leading to outbreak of linezolid-resistant enterococci.Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control studyRisk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex.Antimicrobial stewardship programs in health care systems.Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patientsThe magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae.Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infectionsBloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcomeFluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococciClinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study.Risk factors for isolation of strains susceptible only to polymyxin among patients with Pseudomonas aeruginosa bacteremiaOutcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter speciesEffects of rapid detection of bloodstream infections on length of hospitalization and hospital charges.Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures.Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patientsEpidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.Macrolide resistance in adults with bacteremic pneumococcal pneumonia.Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting.Cefepime-resistant Pseudomonas aeruginosaFluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens.Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.Clinical and Molecular Characteristics of Neonatal Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacteremia: A 12-Year Case-Control-Control Study of a Referral Center in Taiwan.The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance.Editorial commentary: Asking the right questions: morbidity, mortality, and measuring what's important in unbiased evaluations of antimicrobials.
P2860
Q21134706-CCD45BD5-FD9E-4A8D-A9DA-99899D3274D1Q28268161-1CB53050-6FEC-45A8-A962-1C720CFEFF4BQ31047716-2E367A8C-2836-4134-91E2-7277285DAE3CQ33281709-8A07699A-DF6F-4059-8BF5-93DA61BB314CQ33549724-AA06046E-2F0A-4533-BBCA-7FEF0072F834Q33785642-3172E8EF-C302-46E3-83F5-7AC4A73DB243Q33826293-54287482-D7FF-4B50-86DE-E39580714192Q33827095-2A0C3A5E-3155-446A-9B44-54E46BAC6150Q33884094-FAB40A03-AF5A-4ADF-83B2-AA6025119437Q33935336-34BDE092-4706-47EA-9346-398A7684A4AAQ33945413-AFCD2AAD-0CDF-4913-BE8A-25DD78DA91DCQ34009731-D465A3BE-EF2B-4C33-A674-E66034E5C511Q34058025-98EA3199-40FF-417B-95CA-EAB6B32BB290Q34097674-FF60E00B-E2FE-450B-85C2-416F92126FFCQ34113699-4F728584-0EF4-422A-A7D7-FB37A2978719Q34141233-2E93BFDC-830F-4059-A821-72770F6BF97EQ34192567-733B1B96-63D6-41EB-96F3-46FACC5BDADFQ34285984-5AB9B275-D547-494A-9DB4-EEE0AC7DDD9BQ34298840-41E5F87E-2FB1-4775-9C54-A44F70631147Q34351978-0153330F-D019-473D-A955-493EC207D5C4Q34560162-72B39BC4-6B14-4020-8787-CA63D2B98898Q34645156-9B4C1728-C37A-4D17-AB53-3645AA3F5A6EQ34700642-DB6F649D-A38D-44A4-9E45-0D69FA2E69D1Q34721651-68BDD22F-4EBB-40DE-A03F-AC0BAD2EF990Q34869292-20131446-7B72-4AA3-8474-1C27E9C9A280Q34920553-64E93D7A-11C7-452F-B82A-3DA763BAC061Q35014507-81B4E3BD-056C-4401-943C-A037BA6E249BQ35156572-C124B1BA-B2CC-4B58-BEA6-53EBD671DBA8Q35166035-D53B0D3B-A499-48B7-ACB0-045C844F85B0Q35207767-4544A4E5-9556-4463-980A-5B55A79FC61CQ35685012-6FA14EAC-9397-402C-9901-6CF775D8C831Q35689050-B24D7487-0F60-45F1-BF8C-8930CD8A98E9Q35793210-64C163B9-5904-4CDA-9F4B-13BC81FB9F1CQ35853172-2E3C616F-FA5D-453C-947B-AF07618AB8F6Q35872704-1849CB97-0ED8-484A-AAFC-1AA0A85DF146Q35879246-ED6459BA-12AF-425B-89B6-30674B1E99D7Q35921039-52927B13-8AD7-49C5-BC25-D37FBFF416A0Q36098932-7407657F-8C9B-4582-8E20-D465D10C9DF8Q36112353-E31EA998-1EAC-47B2-AB33-BF8B5B6F90C6Q36115620-F303F590-DAC9-4584-80D1-838B2E7B59B3
P2860
Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Methodological principles of c ...... sistance: a systematic review.
@ast
Methodological principles of c ...... sistance: a systematic review.
@en
Methodological principles of c ...... sistance: a systematic review.
@nl
type
label
Methodological principles of c ...... sistance: a systematic review.
@ast
Methodological principles of c ...... sistance: a systematic review.
@en
Methodological principles of c ...... sistance: a systematic review.
@nl
prefLabel
Methodological principles of c ...... sistance: a systematic review.
@ast
Methodological principles of c ...... sistance: a systematic review.
@en
Methodological principles of c ...... sistance: a systematic review.
@nl
P2093
P2860
P356
P1476
Methodological principles of c ...... sistance: a systematic review.
@en
P2093
P2860
P304
P356
10.1086/319600
P407
P577
2001-03-21T00:00:00Z